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  Summary 
Obesity is a steadily increasing global pandemic of western societies. The 
development of type 2 diabetes mellitus is accompanied with obesity that is manifested by 
resistance of metabolic tissues to insulin, thus impairing glucose homeostasis. Moreover, 
obesity correlates with a low-grade chronic inflammation accompanied with macrophage 
infiltration into metabolic tissues and increased levels of circulating cytokines such as IL-6. 
Exercise has a strong potential to ameliorate obesity, allowing for skeletal muscle to clear 
blood glucose independent of insulin. Furthermore, skeletal muscle-derived IL-6 has been 
demonstrated to exert beneficial effects in the periphery by modulating glucose and fatty 
acid metabolism during exercise, but also contributing to the development of insulin 
resistance when chronically elevated.  
While metabolic tissues respond to IL-6 in lean mice, this effect was diminished in 
obese mice due to the development of IL-6 resistance. Moreover, fasting increases IL-6 
secretion by the skeletal muscle, whereas this effect is blunted in obese mice. Since 
skeletal muscle metabolism contributes to glucose homeostasis and is a major target of 
IL-6, we decided to ablate IL-6R specifically in skeletal muscle of mice (IL-6RMuKO mice) 
to investigate the role of skeletal muscle IL-6 signalling in obesity-induced insulin 
resistance and glucose homeostasis. While IL-6RMuKO mice exhibit unaltered body 
composition, HFD accelerates body weight gain due to lean mass increase in IL-6RMuKO 
mice as a consequence of muscle insulin sensitivity. However, IL-6RMuKO mice exposed 
to HFD show a slightly impaired glucose metabolism as a result of reduced IL-10 
secretion, hepatic inflammation and steatosis. Moreover, the insulin-sensitive muscle of 
HFD-fed IL-6RMuKO mice reveals altered mRNA expression of markers for protein 
degradation, energy utilisation and fatty acid metabolism, which results in reduced 
respiration efficiency in quadriceps muscle fibres and presumably alters fibre type 
composition due to insufficient substrate supply. Furthermore, HFD-fed IL-6RMuKO mice 
show decreased skeletal muscle expression of SIRT-1, a potent activator of mitochondrial 
biogenesis underlying the role of skeletal muscle IL-6 action in mitochondrial homeostasis. 
Surprisingly, the altered fiber type composition in HFD-fed IL-6RMuKO mice leads to a 
better training adaptation in treadmill experiments that is reduced in NCD-fed IL-6RMuKO 
mice. Finally, the obesity-induced impairments of glucose homeostasis observed in IL-
6RMuKO mice might be a consequence of decreased fatty acid uptake and -oxidation 
through the insulin-sensitive skeletal muscle thereby leading to hepatic lipid accumulation 
accompanied with infiltration of macrophages. Collectively, these data demonstrate that 
IL-6 exerts beneficial effects to maintain glucose homeostasis, although chronically 
elevated IL-6 under obese conditions is unable to exert these effects due to the 
development of IL-6 resistance. 
 
